Neonatal and adult megakaryopoiesis
- 1 September 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Hematology
- Vol. 18 (5), 330-337
- https://doi.org/10.1097/moh.0b013e3283497ed5
Abstract
It has become increasingly clear that there are substantial biological differences between fetal/neonatal and adult megakaryopoiesis. Over the last 18 months, studies challenged the paradigm that neonatal megakaryocytes are immature and revealed a developmentally unique uncoupling of proliferation, polyploidization, and cytoplasmic maturation. Several studies also described substantial molecular differences between fetal/neonatal and adult megakaryocytes involving transcription factors, signaling pathways, cytokine receptors, and microRNAs. This review will summarize our current knowledge on the developmental differences between fetal/neonatal and adult megakaryocytes, and recent advances in the underlying molecular mechanisms, including differences in transcription factors, in the response to thrombopoietin (Tpo), and newly described developmentally regulated signaling pathways. We will also discuss the implications of these findings on the way megakaryocytes interact with the environment, the response of neonates to thrombocytopenia, and the pathogenesis of Down syndrome-transient myeloproliferative disorder (TMD) and Down syndrome-acute megakaryoblastic leukemia (DS-AMKL). A better characterization of the molecular differences between fetal/neonatal and adult megakaryocytes is critical to elucidating the pathogenesis of a group of disorders that selectively affect fetal/neonatal megakaryocyte progenitors, including the thrombocytopenia-absent radius (TAR) syndrome, Down syndrome-TMD or Down syndrome-AMKL, and the delayed platelet engraftment following cord blood transplantation.Keywords
This publication has 36 references indexed in Scilit:
- Congenital Amegakaryocytic Thrombocytopenia and Thrombocytopenia with Absent RadiiHematology/Oncology Clinics of North America, 2009
- Megakaryocyte Size and Concentration in the Bone Marrow of Thrombocytopenic and Nonthrombocytopenic NeonatesPediatric Research, 2007
- Umbilical Cord Blood Produces Small Megakaryocytes After TransplantationTransplantation and Cellular Therapy, 2007
- Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare systemJournal of Perinatology, 2006
- MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the diseaseHuman Mutation, 2006
- Transient Myeloproliferative Disorder (Transient Leukemia) and Hematologic Manifestations of Down SyndromeClinics In Laboratory Medicine, 1999
- Endogenous Thrombopoietin Levels and Effect of Recombinant Human Thrombopoietin on Megakaryocyte Precursors in Term and Preterm BabiesPediatric Research, 1998
- Thrombopoietin in Patients With Congenital Thrombocytopenia and Absent Radii: Elevated Serum Levels, Normal Receptor Expression, But Defective Reactivity to ThrombopoietinBlood, 1997
- Analysis of Megakaryocyte Ploidy in Fetal Bone Marrow Biopsies Using a New Adaptation of the Feulgen Technique to Measure DNA Content and Estimate Megakaryocyte Ploidy from Biopsy SpecimensPediatric Research, 1996
- Megakaryocytopoiesis in the human fetus.Archives of Disease in Childhood, 1989